The regulatory landscape is evolving: in February 2026, HHS announced that approximately 14 previously restricted peptides including BPC-157, TB-500, CJC-1295, Ipamorelin, and Sermorelin are expected to return to Category 1 compounding status
A similar finding (i.e., rehabilitation of skin wound and maturation of granulation tissue markedly promoted by BPC 157) was obtained in small-type pigs (Xue et al., 2004a)
#Neuroscience #NeuronGlia #DrugDiscovery #Neuropharmacology #DrugDevelopment #Neurodegeneration #BrainHealth #PharmaceuticalResearch To view or add a comment, sign in Recent research has identified specific brain circuits affected by psilocybin, the active compound in certain psychedelic mushrooms, which may offer new approaches for managing chronic pain and depression
Book Now NAD+ 1000 mg (sub-q injections) from AMIV replenish cellular energy, improve focus, boost metabolism, and promote anti-aging and recovery benefits
Hair Growth and Scalp Health For those struggling with thinning hair, Ghk-Cu peptide might offer hope
Investigating their impact on migraines could reveal potential therapeutic benefits or dietary interventions that could alleviate symptoms or prevent migraines